A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
This study has been completed.
Study NCT00044057
Information provided by Astellas Pharma Inc
First Received: August 16, 2002
Last Updated: March 31, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
